45 related articles for article (PubMed ID: 1303177)
1. Molecular analysis of iduronate -2- sulfatase gene in Tunisian patients with mucopolysaccharidosis type II.
Chkioua L; Khedhiri S; Ferchichi S; Tcheng R; Chahed H; Froissart R; Vianey-Saban C; Laradi S; Miled A
Diagn Pathol; 2011 May; 6():42. PubMed ID: 21605424
[TBL] [Abstract][Full Text] [Related]
2. Cognitive and adaptive behaviors associated with disease severity and genotype in patients with mucopolysaccharidosis II.
Yee KS; Alexanderian D; Merberg D; Natarajan M; Wang S; Wu Y; Whiteman DAH
Mol Genet Metab; 2023 Nov; 140(3):107652. PubMed ID: 37506513
[TBL] [Abstract][Full Text] [Related]
3. Fusion of Rabies Virus Glycoprotein or gh625 to Iduronate-2-Sulfatase for the Treatment of Mucopolysaccharidosis Type II.
Wood SR; Chaudrhy A; Ellison S; Searle R; Burgod C; Tehseen G; Forte G; O'Leary C; Gleitz H; Liao A; Cook J; Holley R; Bigger BW
Hum Gene Ther; 2024 Apr; 35(7-8):232-242. PubMed ID: 37212263
[TBL] [Abstract][Full Text] [Related]
4. Lentiviral Gene Therapy for Mucopolysaccharidosis II with Tagged Iduronate 2-Sulfatase Prevents Life-Threatening Pathology in Peripheral Tissues But Fails to Correct Cartilage.
Catalano F; Vlaar EC; Dammou Z; Katsavelis D; Huizer TF; Zundo G; Hoogeveen-Westerveld M; Oussoren E; van den Hout HJMP; Schaaf G; Pike-Overzet K; Staal FJT; van der Ploeg AT; Pijnappel WWMP
Hum Gene Ther; 2024 Apr; 35(7-8):256-268. PubMed ID: 38085235
[TBL] [Abstract][Full Text] [Related]
5. Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment.
D'Avanzo F; Rigon L; Zanetti A; Tomanin R
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070051
[TBL] [Abstract][Full Text] [Related]
6. Functional assessment of the genetic findings indicating mucopolysaccharidosis type II in the prenatal setting.
Fuller M; Ketteridge D
JIMD Rep; 2021 Jul; 60(1):10-14. PubMed ID: 34258136
[TBL] [Abstract][Full Text] [Related]
7. Case Report: Holistic dental care for a child with Hunter syndrome: Addressing dental ramifications, overcoming challenges, and enhancing quality of life.
Saha S; Priya K; Rai K; R M; Shetty K; M Hegde A; Rao K A; Abhijit Tanna D; S M; S S
F1000Res; 2024; 13():268. PubMed ID: 38812528
[TBL] [Abstract][Full Text] [Related]
8. Detection of Structural Variants by NGS: Revealing Missing Alleles in Lysosomal Storage Diseases.
La Cognata V; Cavallaro S
Biomedicines; 2022 Jul; 10(8):. PubMed ID: 36009380
[TBL] [Abstract][Full Text] [Related]
9. Molecular diagnosis of patients affected by mucopolysaccharidosis: a multicenter study.
Zanetti A; D'Avanzo F; Rigon L; Rampazzo A; Concolino D; Barone R; Volpi N; Santoro L; Lualdi S; Bertola F; Scarpa M; Tomanin R
Eur J Pediatr; 2019 May; 178(5):739-753. PubMed ID: 30809705
[TBL] [Abstract][Full Text] [Related]
10. Deep Genotyping of the IDS Gene in Colombian Patients with Hunter Syndrome.
Galvis J; González J; Uribe A; Velasco H
JIMD Rep; 2015; 19():101-9. PubMed ID: 25681085
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of iduronate-2-sulphatase gene mutations in patients with mucopolysaccharidosis type II (Hunter syndrome).
Li P; Bellows AB; Thompson JN
J Med Genet; 1999 Jan; 36(1):21-7. PubMed ID: 9950361
[TBL] [Abstract][Full Text] [Related]
12. Hunter disease in the Spanish population: molecular analysis in 31 families.
Gort L; Chabás A; Coll MJ
J Inherit Metab Dis; 1998 Aug; 21(6):655-61. PubMed ID: 9762601
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the iduronate-2-sulfatase gene in five Norwegians with Hunter syndrome.
Olsen TC; Eiken HG; Knappskog PM; Kase BF; Månsson JE; Boman H; Apold J
Hum Genet; 1996 Feb; 97(2):198-203. PubMed ID: 8566953
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis in patients with mucopolysaccharidosis type II suggests that DXS466 maps within the Hunter gene.
Steglich C; Bunge S; Hulsebos T; Beck M; Brandt NJ; Schwinger E; Hopwood JJ; Gal A
Hum Genet; 1993 Sep; 92(2):179-82. PubMed ID: 8103756
[TBL] [Abstract][Full Text] [Related]
15. Molecular diagnosis of mucopolysaccharidosis type II (Hunter syndrome) by automated sequencing and computer-assisted interpretation: toward mutation mapping of the iduronate-2-sulfatase gene.
Jonsson JJ; Aronovich EL; Braun SE; Whitley CB
Am J Hum Genet; 1995 Mar; 56(3):597-607. PubMed ID: 7887413
[TBL] [Abstract][Full Text] [Related]
16. Evidence for an iduronate-sulfatase pseudogene near the functional Hunter syndrome gene in Xq27.3-q28.
Rathmann M; Bunge S; Steglich C; Schwinger E; Gal A
Hum Genet; 1995 Jan; 95(1):34-8. PubMed ID: 7814022
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of DNA and RNA in Hunter patients.
Annella T; Daniele A; Di Natale P
Hum Genet; 1993 Oct; 92(4):350-2. PubMed ID: 7693576
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of patients with Hunter syndrome: implication of a region prone to structural alterations within the IDS gene.
Steén-Bondeson ML; Dahl N; Tönnesen T; Kleijer WJ; Seidlitz G; Gustavson KH; Wilson PJ; Morris CP; Hopwood JJ; Pettersson U
Hum Mol Genet; 1992 Jun; 1(3):195-8. PubMed ID: 1303177
[TBL] [Abstract][Full Text] [Related]
19. Frequent deletions at Xq28 indicate genetic heterogeneity in Hunter syndrome.
Wilson PJ; Suthers GK; Callen DF; Baker E; Nelson PV; Cooper A; Wraith JE; Sutherland GR; Morris CP; Hopwood JJ
Hum Genet; 1991 Mar; 86(5):505-8. PubMed ID: 1901826
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
